Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register - Schäfer, M; Purschke, A; Zietemann, V (Ann Rheum Dis, 2025)
Online ahead of print.